Healthcare & Life Sciences News and Articles

Google News – Pharmaceuticals External News

Hengrui Pharmaceuticals Calls Extraordinary Meeting on New Share Schemes and Buyback Mandate - TipRanks

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Fine Foods & Pharmaceuticals H1 EBITDA Adj. €15.2 Mln, EBITDA Margin Adj. At 12.2% - TradingView

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

MONDAY REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 14, 2026 Deadline - RGRD Law - marketscreener.com

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

MONDAY REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, - GlobeNewswire

news.google.com · 08 Sep 2026

Google News – Biopharma External News

Why Did Quantum BioPharma (CN:TCM) Stock Surge 6.846% on 4 September 2026? - kalkine.ca

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Pharma Eupraxia (Nasdaq: EPRX) moves to Nasdaq's top tier - Stock Titan

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Tonix Pharmaceuticals Holding Corp. Announces Appointment of Thomas Englese to Chief Commercial Officer, Effective September 8, 2026 - marketscreener.com

news.google.com · 08 Sep 2026

Google News – Oncology External News

Medicus Pharma shifts focus to precision oncology with CD228V By Investing.com - Investing.com Canada

news.google.com · 08 Sep 2026

Google News – Biopharma External News

BrainChild hauls in $116M to make cell therapies for childhood brain cancers - BioPharma Dive

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session - Benzinga

news.google.com · 08 Sep 2026

Google News – Clinical Trials External News

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE) - Intellia Therapeutics

news.google.com · 08 Sep 2026

Industry News External News

After Cigna dropped GLP-1 coverage, employees started a petition

hrexecutive.com · 08 Sep 2026

Google News – Pharmaceuticals External News

PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer - GlobeNewswire

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq - GlobeNewswire

news.google.com · 08 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

Hengrui Pharmaceuticals Calls Extraordinary Meeting on New Share Schemes and Buyback Mandate - TipRanks

Fine Foods & Pharmaceuticals H1 EBITDA Adj. €15.2 Mln, EBITDA Margin Adj. At 12.2% - TradingView

MONDAY REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 14, 2026 Deadline - RGRD Law - marketscreener.com

MONDAY REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, - GlobeNewswire

Why Did Quantum BioPharma (CN:TCM) Stock Surge 6.846% on 4 September 2026? - kalkine.ca

Pharma Eupraxia (Nasdaq: EPRX) moves to Nasdaq's top tier - Stock Titan

Tonix Pharmaceuticals Holding Corp. Announces Appointment of Thomas Englese to Chief Commercial Officer, Effective September 8, 2026 - marketscreener.com

Medicus Pharma shifts focus to precision oncology with CD228V By Investing.com - Investing.com Canada

BrainChild hauls in $116M to make cell therapies for childhood brain cancers - BioPharma Dive

Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session - Benzinga

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE) - Intellia Therapeutics

After Cigna dropped GLP-1 coverage, employees started a petition

PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer - GlobeNewswire

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire

Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq - GlobeNewswire